Date

Tuesday, 07 September 2021

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Agenda - COMP agenda of the 7-9 September 2021 meeting

COMP meeting report on the review of applications for orphan designation: September 2021

Minutes of the COMP meeting 7-9 September 2021

How useful do you find this page?